This protocol is judged by an institutional evaluate board, an independent team that assessments any clinical trials involving people. If a study entails a Schedule I drug, as soon as the board approves the protocol as ethical, the researchers need to submit an application for an investigational new drug (IND) number from the FDA.copyright to star